NDC11 50222036111
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 50222-0361-11 | 50222-0361 |
| 50222-361-11 | 50222-361 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SPEVIGO | SPESOLIMAB | LEO Pharma Inc. | 78a4f7eb-8d34-4467-8d40-74ed24323806 | 2026-03-16 | Warnings, Adverse reactions | 50222-361-11 50222-361 50222036111 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.